Full name
"PHARMABEST" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"PHARMABEST" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. RUMIANA 31 A, 02-956 WARSZAWA
TAX ID9512335808
Rate company:
"PHARMABEST" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9512335808
KRS0000380585
Share capital100,000.00 zł
address
UL. RUMIANA 31 A, 02-956 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9512335808
REGON
142698306
KRS
0000380585
Legal form
limited liability company
Register Address
UL. RUMIANA 31 A, 02-956 WARSZAWA
Date of registration in KRS
2011-03-17
Date of commencement of economic activity
2011-03-17
Act signature
WA.XIII NS-REJ.KRS/4266/23/829/ADE
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.34.B - Wholesale trade of non-alcoholic beverages
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
Payer VAT status
Active
Vat list bank account(s)
PL32 1090 2590 0000 0001 4486 1064 
PL45 1090 2590 0000 0001 2269 9628 
PL50 1030 0019 0109 8530 0032 4367 PL79 1090 2590 0000 0001 2269 9598 Show more bank accounts from VAT list (1)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 3 | 8,2 | ||
Gross profit (loss) | 2,9 | 5,3 | 6,8 | 26,9 |
EBITDA | 3 | 5,4 | 6,6 | 23,1 |
Short time liabilities | 7,1 | 11,7 | 9,9 | -15,5 |
Other operating costs | 0 | -65,8 | ||
Equity capital | 2,4 | 7,4 | 8,3 | 12,1 |
Operating profit (EBIT) | 3 | 5,4 | 6,5 | 21,7 |
Assets | 10,6 | 19,1 | 18,1 | -4,9 |
Net profit (loss) | 2,3 | 5,3 | 5,9 | 11 |
Cash | 1,9 | 0,1 | 0 | -17,6 |
Net income from sale | 37,7 | 48,9 | 52,5 | 7,5 |
Liabilities and provisions for liabilities | 8,2 | 11,7 | 9,9 | -15,6 |
Working assets | 10,6 | 19,1 | 18,1 | -4,9 |
Other income costs | 0 | -81,9 | ||
Depreciation | 0 | 0 | 0,1 | 587,8 |
% | % | % | p.p. | |
Profitability of capital | 92,8 | 71,7 | 71,1 | -0,6 |
Equity capital to total assets | 23 | 38,8 | 45,7 | 6,9 |
Gross profit margin | 7,8 | 10,9 | 12,9 | 2 |
EBITDA Margin | 8,1 | 11 | 12,6 | 1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 69 | 87 | 68 | -19 |
Current financial liquidity indicator | 1.4865562915802002 | 1.6341291666030884 | 1.8423516750335693 | 0,2 |
Net dept to EBITDA | -0.032978273928165436 | 0.016318924725055695 | -0.007323247380554676 | 0 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download docx01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download xml01-01-2023 - 31-12-2023
Activity report
Download xml01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download xml01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download xmlShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
MEDDENT PEREK,LEWICKI
Kraków
Gama Sp. z o.o.
Ruda Śląska
Bioevolution sp. z o.o. sp.k.
Warszawa
CYTOGEN-POLSKA
ŁÓDŹ
Interton.pl sp. z o.o.
Kraków
CMS Polska sp. z o.o.
Rzeszów